| Date | Time | Source | Headline | Symbol | Company |
| 03/18/2010 | 6:50AM | GlobeNewswire Inc. | Biotech Stock Alert for AVI BioPharma Inc. Issued by Beacon Equity | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/16/2010 | 7:15AM | Marketwired | AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/16/2010 | 6:08AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/10/2010 | 7:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/09/2010 | 8:00AM | Marketwired | AVI BioPharma Announces Fourth Quarter and Full Year 2009 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/08/2010 | 5:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/15/2010 | 8:00AM | Marketwired | AVI BioPharma Receives Grants Totaling $500,000 From CureDuchenne and the Foundation to Eradicate Duchenne to Support Continuing | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 8:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/11/2010 | 5:15PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/05/2010 | 8:00AM | Marketwired | AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation for Duchenne Muscular Dystrophy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 02/04/2010 | 8:00AM | Marketwired | AVI BioPharma GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 01/19/2010 | 6:03AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/23/2009 | 5:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 12/22/2009 | 7:00AM | Marketwired | Systemic Treatment With AVI-4658 Demonstrates RNA Exon Skipping and Dystrophin Protein Expression in Duchenne Muscular Dystrophy | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/19/2009 | 8:00AM | Marketwired | AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/18/2009 | 8:00AM | Marketwired | AVI BioPharma, Inc. to Present at Transformational Medical Technologies Initiative (TMTI) Industry Day | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2009 | 1:29PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2009 | 8:00AM | Marketwired | AVI BioPharma Announces Third Quarter 2009 Financial Results & Corporate Highlights | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/09/2009 | 6:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 11/02/2009 | 8:00AM | Marketwired | AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/26/2009 | 8:00AM | Marketwired | AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International C | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/22/2009 | 8:00AM | Marketwired | AVI BioPharma to Present Safety Update From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Confe | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/20/2009 | 10:00AM | Marketwired | Exon Skipping Drug Prevents Muscle Wasting and Maintains Muscle Function in Severely Affected, Dystrophin Deficient Mice | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 10/19/2009 | 9:36PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |